DarioHealth (DRIO) Competitors $0.71 +0.00 (+0.42%) As of 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRIO vs. LUNG, LUCD, OBIO, NTRB, MGRM, ICAD, ZJYL, FONR, MBOT, and APYXShould you be buying DarioHealth stock or one of its competitors? The main competitors of DarioHealth include Pulmonx (LUNG), Lucid Diagnostics (LUCD), Orchestra BioMed (OBIO), Nutriband (NTRB), Monogram Orthopaedics (MGRM), icad (ICAD), Jin Medical International (ZJYL), Fonar (FONR), Microbot Medical (MBOT), and Apyx Medical (APYX). These companies are all part of the "medical equipment" industry. DarioHealth vs. Its Competitors Pulmonx Lucid Diagnostics Orchestra BioMed Nutriband Monogram Orthopaedics icad Jin Medical International Fonar Microbot Medical Apyx Medical DarioHealth (NASDAQ:DRIO) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability. Do institutionals and insiders have more ownership in DRIO or LUNG? 33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 91.0% of Pulmonx shares are owned by institutional investors. 11.2% of DarioHealth shares are owned by insiders. Comparatively, 6.8% of Pulmonx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to DRIO or LUNG? In the previous week, DarioHealth and DarioHealth both had 1 articles in the media. DarioHealth's average media sentiment score of 1.29 beat Pulmonx's score of 0.93 indicating that DarioHealth is being referred to more favorably in the media. Company Overall Sentiment DarioHealth Positive Pulmonx Positive Is DRIO or LUNG more profitable? Pulmonx has a net margin of -65.27% compared to DarioHealth's net margin of -159.80%. Pulmonx's return on equity of -63.69% beat DarioHealth's return on equity.Company Net Margins Return on Equity Return on Assets DarioHealth-159.80% -65.81% -38.41% Pulmonx -65.27%-63.69%-34.94% Do analysts prefer DRIO or LUNG? DarioHealth currently has a consensus target price of $2.00, suggesting a potential upside of 180.90%. Pulmonx has a consensus target price of $11.53, suggesting a potential upside of 325.28%. Given Pulmonx's higher probable upside, analysts plainly believe Pulmonx is more favorable than DarioHealth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DarioHealth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Pulmonx 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.63 Which has more risk & volatility, DRIO or LUNG? DarioHealth has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, Pulmonx has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Which has stronger earnings & valuation, DRIO or LUNG? DarioHealth has higher earnings, but lower revenue than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDarioHealth$27.04M1.17-$42.75M-$0.56-1.27Pulmonx$83.79M1.30-$56.39M-$1.44-1.88 SummaryPulmonx beats DarioHealth on 8 of the 15 factors compared between the two stocks. Get DarioHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for DRIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DRIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRIO vs. The Competition Export to ExcelMetricDarioHealthMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$31.66M$6.65B$5.56B$9.30BDividend YieldN/A1.20%4.23%4.03%P/E Ratio-1.2725.4828.6119.64Price / Sales1.1787.29437.49188.30Price / CashN/A20.3636.0257.93Price / Book0.344.648.185.63Net Income-$42.75M$174.76M$3.23B$257.73M7 Day Performance-1.11%-1.50%-0.25%0.07%1 Month Performance2.24%0.92%5.40%8.32%1 Year Performance-47.26%2.17%26.35%13.78% DarioHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRIODarioHealth1.9185 of 5 stars$0.71+0.4%$2.00+180.9%-51.1%$31.66M$27.04M-1.27200Positive NewsLUNGPulmonx3.4467 of 5 stars$2.64-5.0%$11.53+336.6%-65.2%$111.92M$83.79M-1.83250LUCDLucid Diagnostics2.5969 of 5 stars$1.04+1.0%$3.55+241.3%+32.9%$111.43M$4.35M-0.7870News CoveragePositive NewsAnalyst ForecastGap UpHigh Trading VolumeOBIOOrchestra BioMed2.9183 of 5 stars$2.89flat$14.20+391.3%-65.8%$110.72M$2.64M-1.624NTRBNutriband3.0496 of 5 stars$8.47-14.5%$13.00+53.5%+18.3%$110.54M$2.14M-9.4110Gap DownMGRMMonogram Orthopaedics1.0391 of 5 stars$2.91+0.3%$5.40+85.6%+173.1%$103.50M$370K-6.4728ICADicad0.6905 of 5 stars$3.71-1.3%N/A+198.4%$103.29M$19.53M-19.53140News CoverageZJYLJin Medical InternationalN/A$0.58-10.1%N/A-79.3%$100.21M$23.50M0.00245News CoveragePositive NewsGap UpFONRFonar1.2177 of 5 stars$15.46-0.9%N/A-4.8%$96.77M$102.88M12.37480MBOTMicrobot Medical2.2636 of 5 stars$2.51-3.5%$9.00+258.6%+126.5%$94.58MN/A-3.8620APYXApyx Medical2.1927 of 5 stars$2.58+12.7%N/A+49.6%$86.55M$48.10M-4.69270Positive NewsHigh Trading Volume Related Companies and Tools Related Companies LUNG Alternatives LUCD Alternatives OBIO Alternatives NTRB Alternatives MGRM Alternatives ICAD Alternatives ZJYL Alternatives FONR Alternatives MBOT Alternatives APYX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRIO) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DarioHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DarioHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRIO Stock Alerts